-
In the summer of 2019, Bora was celebrating his mother’s birthday at a seaside restaurant in Istanbul when he suddenly became very ill and couldn’t finish his meal.
-
We’re committed to increasing diverse representation in clinical trials, especially for those who have been historically underrepresented.
-
Dale, who is living with breast cancer, shares her journey and point of view about how sharing information can help reduce health disparities.
-
At Gilead, we’re focused on fighting devastating diseases and delivering innovative medicines that offer new hope for patients. Also important, though, is our work to make sure that we remove barriers to care and reach the people that need our therapies.
-
This year’s theme for National Black HIV/AIDS Awareness Day is “Engage, Educate, Empower: Uniting to End HIV/AIDS in Black Communities.”
-
Gilead Sciences, Inc. (Nasdaq: GILD) announced it is providing a total of $12.6 million in grant funding to 19 organizations working to improve the HIV landscape for Black women and girls in the United States.
-
This year’s theme for National Black HIV/AIDS Awareness Day is “Engage, Educate, Empower: Uniting to End HIV/AIDS in Black Communities.”
-
Gilead Sciences, Inc. (Nasdaq: GILD) announced the company has been named one of America’s Most JUST Companies.
-
Long-time liver specialist Carrie Frenette says she won’t ever forget the people she treated for hepatitis C (HCV) before 2013 – the year that the Food and Drug Administration (FDA) approved a Gilead medicine. The medicine was the first curative therapy for HCV.
-
We’re proud to offer an inclusive culture that enables all people to do their best work, and we’re happy to be named one of Newsweek America’s Greatest Workplaces for Diversity for our efforts.
-
The personal journeys of six people in the United Kingdom living with HIV, hepatitis C and cancer – and the challenges they face due to stigma and health inequities – come together in the form of a new, intentionally difficult-to-read book from Gilead.
-
For the past 30 years, Pilar Fernandez has navigated living with metastatic breast cancer. And while she’s faced a series of related health challenges, it hasn’t slowed her down.
-
“It's an experience that I hope no one goes through, but it's an empowering experience.”
-
When employees at Gilead’s recently opened New Jersey office need a place to meet, the “Cara” conference room is one such place they gather. Given the room’s namesake, it’s especially fitting when the topic at hand is the company’s oncology work.
-
Gilead Sciences, Inc. (Nasdaq: GILD) announced the company has once again been recognized as one of the most sustainable pharmaceutical companies according to the Dow Jones Sustainability World Index (DJSI World) for the third consecutive year.
-
We're proud to have contributed to this milestone announced by the World Health Organization - marking the elimination of visceral leishmaniasis (VL) as a public health problem in Bangladesh.
-
When Shirley Cantin was a law student, about half of her classmates were women. Yet when she joined a corporate law firm, Shirley noticed that most of its leaders were white men. And when she left a decade later, little progress on the leadership team’s diversity had been made.
-
Gilead Sciences, Inc. announced it will present new data at San Antonio Breast Cancer Symposium 2023, supporting the use of Trodelvy® (sacituzumab govitecan-hziy) in certain metastatic triple-negative breast cancer and pre-treated HR+/HER2- metastatic breast cancer patients.
-
Nearly 36 years ago the AIDS Memorial Quilt was displayed for the first time to memorialize and physically represent lives lost to HIV. Gilead has always actively supported the Quilt, and creating a new panel made sense for a company dedicated to helping end the HIV epidemic.
-
Through our community partnerships in low-and-middle-income countries, we are working together to expand access and reduce barriers to care while embracing innovation.
-
Claudia Hardy says she’s found her life’s mission. As director of Community Health Access and Relations for the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, she brings cancer resources and preventive care to communities.
-
Gilead Sciences, Inc. (Nasdaq: GILD) was recognized as the number one philanthropic funder of HIV-related programs for the second year in a row, in a new report released by Funders Concerned About AIDS (FCAA).
-
Dr. Shringar Rao’s inquisitive nature and dedication to addressing health inequities drive her eagerness to help advance innovative scientific breakthroughs.
-
Since the pledge, Gilead has continued its long history in supporting reducing deaths from VL and controlling other neglected tropical diseases such as cryptococcal meningitis in efforts to advance global health equity.
-
Over the years, Gilead has thoughtfully and boldly focused on communities with the greatest unmet needs, and women and girls – in particular, Black women and girls – are always at the top of the list.
-
Shortly after Sandra joined Gilead, this company ambition touched close to home. She worked on an acquisition that ended up being the backbone of Gilead’s work to develop a cure for hepatitis C.
-
As an elementary school student, Nohely Peraza took a bus from her home in East Palo Alto to a school several miles away in another city.
-
This year marks the fifth anniversary of the Gilead COMPASS Initiative®, a 10-year, more than $100 million commitment to addressing the HIV epidemic in the Southern United States.
-
When Stacey Ma was a little girl, her dream was to work with patients as a doctor. “As it turns out, I became an engineer who makes medicine to help patients,” says Stacey, who joined Gilead last summer to lead the Pharmaceutical Development and Manufacturing (PDM) team
-
Gilead has been at the forefront of helping transform the treatment and prevention of HIV for decades, and it is also focused on helping speed the development and accessibility of new medications for children.
-
Gilead provided a grant for the innovative partnership as part of its overall efforts to advance health equity and reduce stigma and disparities in communities of greatest need.
-
Gilead Sciences Inc. (Nasdaq: GILD) announced its largest commitment to health equity for Australian and Canadian Indigenous communities.
-
Across the country, LGBTQ+ youth face challenges that are negatively affecting their mental health. Some find themselves not feeling accepted by their family or friends, or being verbally harassed at school.
-
With support from partners, including Gilead, Joe went on to co-found the Oakland LGBTQ Community Center, which opened its doors in 2017.
-
Through the GAIN community, Abbey has also started to dig deeper into her identity as a Korean American woman in her field.
-
Marion grew up very healthy, never even getting colds or the flu – but that changed as she got older.
-
After finishing medical school in the late 1990s, Bilal Piperdi wanted to follow his mentor into the field of thoracic oncology, the specialized area that focuses on lung cancer.
-
When LJ Mizzi joined Gilead in 2013, she already had a personal connection to the company. “A Gilead medicine saved the life of a loved one, so I was excited to begin a career here and to contribute in any way I could,” LJ says.
-
When Jamari Brooks was looking for a new job last fall, he knew he wanted his future employer to have a few key qualities.
-
The recent national conversation on hepatitis C (HCV) is an encouraging step towards viral hepatitis elimination in the U.S. With its long history of leadership in viral hepatitis, Gilead continues to support efforts that focus on HCV elimination.
-
Gilead Sciences recently released its inaugural Environmental, Social and Governance (ESG) Impact Report.
-
When I came to Gilead in 2019, I did so in part because of the revolutionary way this company thinks about bringing therapies to those who could benefit.
-
We sat down with Dan Murphy and Dr. Jeffrey Lazarus to discuss the work that needs to be done to meet the United Nations' (U.N.) goal of ending the HIV epidemic by 2030 and to fully meet the needs of people living with HIV around the world.
-
Early in 2020, Keith Prowell was making the most of his retirement in New York and staying active with swimming and tai chi. But as reports of a new, unknown virus started spreading, he began not feeling well.
-
KM Uploading / MI approved.
-
Moore, who set the course for the future of the semiconductor industry, devoted his later years to philanthropy.
-
Every Friday for more than two years, a community church in North Wales, U.K., would transform into a one-stop shop of social services for people experiencing homelessness. Everything from housing to haircuts, mental health services and foot care by local podiatrists were offered
-
Stacey came to Gilead last year because of its legacy and leadership in advancing health equity and access for underrepresented communities.
-
Many of the communities who could most benefit from pre-exposure prophylaxis (PrEP) for HIV prevention haven’t been included in clinical trial design and execution over the years – but Gilead’s PURPOSE studies made their inclusion a primary goal.
-
As a way to support those impacted by Monday’s devastating earthquake in Türkiye and Syria, the Gilead Foundation is donating $1 million for on-the-ground relief efforts.